Drugs Information: Sipuleucel-T
Basic Information
|
||
| ID | DDInter1677 | |
| Drug Type | biotech | |
| Molecular Formula | None | |
| Molecular Weight | - | |
| Description | Sipuleucel-T is an autologous cellular immunotherapy indicated for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer. | |
| ATC Classification | L03AX17 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Sipuleucel-T
| Severity level | ID | Name | Mechanism | Detail |
|---|